CSE Bulletin: Fundamental Change - Cyntar Ventures Inc./Clearmind Medicine Inc.
- Written by Newsfile
Toronto, Ontario--(Newsfile Corp. - Le 21 mai/May 2021) Clearmind Medicine Inc., the issuer resulting from a Fundamental Change of Cyntar Ventures Inc. (CYN), has been approved for listing.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
Clearmind develops novel psychedelic...
Read more: CSE Bulletin: Fundamental Change - Cyntar Ventures Inc./Clearmind Medicine Inc.

